132 related articles for article (PubMed ID: 33537135)
21. Emergence and characterization of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae isolates from blood samples of patients in intensive care units in northern China.
Xu H; Zhou Y; Zhai X; Du Z; Wu H; Han Y; Huo C; Chen Y
J Med Microbiol; 2016 Aug; 65(8):751-759. PubMed ID: 27324378
[TBL] [Abstract][Full Text] [Related]
22. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
DiPersio JR; Dowzicky MJ
Int J Antimicrob Agents; 2007 May; 29(5):518-27. PubMed ID: 17376657
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
Dowzicky MJ; Chmelařová E
J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
[TBL] [Abstract][Full Text] [Related]
24. Multidrug-resistant Gram-negative infections: what are the treatment options?
Giamarellou H; Poulakou G
Drugs; 2009 Oct; 69(14):1879-901. PubMed ID: 19747006
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004-2014.
Marco F; Dowzicky MJ
J Glob Antimicrob Resist; 2016 Sep; 6():50-56. PubMed ID: 27530839
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
Morfin-Otero R; Noriega ER; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
[TBL] [Abstract][Full Text] [Related]
27. [In vitro activity of tigecycline against multiple resistant Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae isolates].
Arikan Akan O; Uysal S
Mikrobiyol Bul; 2008 Apr; 42(2):209-15. PubMed ID: 18697418
[TBL] [Abstract][Full Text] [Related]
28. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
Roy S; Datta S; Viswanathan R; Singh AK; Basu S
J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
[TBL] [Abstract][Full Text] [Related]
29. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
Pfaller MA; Huband MD; Streit JM; Flamm RK; Sader HS
Int J Antimicrob Agents; 2018 Jun; 51(6):848-853. PubMed ID: 29410368
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
31. The Resistance Mechanism and Clonal Distribution of Tigecycline-Nonsusceptible Klebsiella pneumoniae Isolates in Korea.
Ahn C; Yoon SS; Yong TS; Jeong SH; Lee K
Yonsei Med J; 2016 May; 57(3):641-6. PubMed ID: 26996563
[TBL] [Abstract][Full Text] [Related]
32. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
[TBL] [Abstract][Full Text] [Related]
33. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
[TBL] [Abstract][Full Text] [Related]
34. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
35.
Pfaller MA; Li L; Liu Q; Zhang J; Huband MD; Lindley JM; Mendes RE
JAC Antimicrob Resist; 2021 Dec; 3(4):dlab177. PubMed ID: 34917942
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility of Klebsiella spp. to tigecycline and other selected antibiotics.
Sekowska A; Gospodarek E
Med Sci Monit; 2010 Jun; 16(6):BR193-6. PubMed ID: 20512088
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand.
Eiamphungporn W; Yainoy S; Jumderm C; Tan-Arsuwongkul R; Tiengrim S; Thamlikitkul V
J Glob Antimicrob Resist; 2018 Dec; 15():32-35. PubMed ID: 29935331
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
39. Comparative activity of tigecycline and tetracycline on Gram-negative and Gram-positive bacteria revealed by a multicentre study in four North European countries.
Nilsson LE; Frimodt-Møller N; Vaara M; Simonsen GS;
Scand J Infect Dis; 2011 Sep; 43(9):707-13. PubMed ID: 21619494
[TBL] [Abstract][Full Text] [Related]
40. In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline.
Huang TD; Berhin C; Bogaerts P; Glupczynski Y
J Antimicrob Chemother; 2012 Nov; 67(11):2696-9. PubMed ID: 22833638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]